Titre : Épilepsie partielle complexe

Épilepsie partielle complexe : Questions médicales fréquentes

Termes MeSH sélectionnés :

alpha-Linolenic Acid
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Épilepsie partielle complexe : Questions médicales les plus fréquentes", "headline": "Épilepsie partielle complexe : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Épilepsie partielle complexe : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-30", "dateModified": "2025-04-24", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Épilepsie partielle complexe" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Épilepsies partielles", "url": "https://questionsmedicales.fr/mesh/D004828", "about": { "@type": "MedicalCondition", "name": "Épilepsies partielles", "code": { "@type": "MedicalCode", "code": "D004828", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C10.228.140.490.360" } } }, "about": { "@type": "MedicalCondition", "name": "Épilepsie partielle complexe", "alternateName": "Epilepsy, Complex Partial", "code": { "@type": "MedicalCode", "code": "D017029", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Xiao-Rong Liu", "url": "https://questionsmedicales.fr/author/Xiao-Rong%20Liu", "affiliation": { "@type": "Organization", "name": "Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China." } }, { "@type": "Person", "name": "Yong-Hong Yi", "url": "https://questionsmedicales.fr/author/Yong-Hong%20Yi", "affiliation": { "@type": "Organization", "name": "Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China." } }, { "@type": "Person", "name": "Jie Wang", "url": "https://questionsmedicales.fr/author/Jie%20Wang", "affiliation": { "@type": "Organization", "name": "Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China." } }, { "@type": "Person", "name": "Wei-Ping Liao", "url": "https://questionsmedicales.fr/author/Wei-Ping%20Liao", "affiliation": { "@type": "Organization", "name": "Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Investigating the effects of co-supplementation with alpha-linolenic acid and L-carnitine on inflammatory status, oxidative stress, clinical symptoms, mental health and quality of life in women with migraine: a protocol for a randomized, triple-blind, placebo-controlled trial.", "datePublished": "2024-10-08", "url": "https://questionsmedicales.fr/article/39380085", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13063-024-08500-3" } }, { "@type": "ScholarlyArticle", "name": "Proteomic Analysis Reveals the Association between the Pathways of Glutathione and α-Linolenic Acid Metabolism and Lanthanum Accumulation in Tea Plants.", "datePublished": "2023-01-23", "url": "https://questionsmedicales.fr/article/36770792", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/molecules28031124" } }, { "@type": "ScholarlyArticle", "name": "Distinct effects of α-linolenic acid and docosahexaenoic acid on the expression of genes related to cholesterol metabolism and the response to infection in THP-1 monocytes and immune cells of obese humans.", "datePublished": "2023-01-06", "url": "https://questionsmedicales.fr/article/36621145", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.biopha.2022.114167" } }, { "@type": "ScholarlyArticle", "name": "Identification of transcription factor BnHDG4-A08 as a novel candidate associated with the accumulation of oleic, linoleic, linolenic, and erucic acid in Brassica napus.", "datePublished": "2024-10-01", "url": "https://questionsmedicales.fr/article/39352575", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00122-024-04733-7" } }, { "@type": "ScholarlyArticle", "name": "One-pot synthesis of α-Linolenic acid nanoemulsion-templated drug-loaded silica mesocomposites as efficient bactericide against drug-resistant Mycobacterium tuberculosis.", "datePublished": "2022-07-15", "url": "https://questionsmedicales.fr/article/35840102", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ejps.2022.106261" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système nerveux", "item": "https://questionsmedicales.fr/mesh/D009422" }, { "@type": "ListItem", "position": 3, "name": "Maladies du système nerveux central", "item": "https://questionsmedicales.fr/mesh/D002493" }, { "@type": "ListItem", "position": 4, "name": "Encéphalopathies", "item": "https://questionsmedicales.fr/mesh/D001927" }, { "@type": "ListItem", "position": 5, "name": "Épilepsie", "item": "https://questionsmedicales.fr/mesh/D004827" }, { "@type": "ListItem", "position": 6, "name": "Épilepsies partielles", "item": "https://questionsmedicales.fr/mesh/D004828" }, { "@type": "ListItem", "position": 7, "name": "Épilepsie partielle complexe", "item": "https://questionsmedicales.fr/mesh/D017029" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Épilepsie partielle complexe - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Épilepsie partielle complexe", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Épilepsie partielle complexe", "description": "Comment diagnostique-t-on l'épilepsie partielle complexe ?\nQuels tests sont utilisés pour confirmer le diagnostic ?\nLes symptômes peuvent-ils varier d'un patient à l'autre ?\nQuel rôle joue l'historique médical dans le diagnostic ?\nPeut-on diagnostiquer l'épilepsie partielle complexe chez les enfants ?", "url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=alpha-Linolenic+Acid&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Épilepsie partielle complexe", "description": "Quels sont les symptômes typiques des crises ?\nLes crises peuvent-elles affecter la mémoire ?\nComment se manifestent les comportements automatisés ?\nLes crises peuvent-elles être précédées d'aura ?\nLes symptômes peuvent-ils persister après la crise ?", "url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=alpha-Linolenic+Acid&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Épilepsie partielle complexe", "description": "Peut-on prévenir les crises d'épilepsie partielle complexe ?\nQuels sont les déclencheurs courants des crises ?\nL'éducation des proches est-elle importante ?\nLes activités physiques sont-elles sûres ?\nComment gérer le stress pour prévenir les crises ?", "url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=alpha-Linolenic+Acid&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Épilepsie partielle complexe", "description": "Quels médicaments sont couramment prescrits ?\nLa chirurgie est-elle une option de traitement ?\nQuelles sont les alternatives aux médicaments ?\nComment évaluer l'efficacité du traitement ?\nLes changements de mode de vie peuvent-ils aider ?", "url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=alpha-Linolenic+Acid&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Épilepsie partielle complexe", "description": "Quelles sont les complications possibles de l'épilepsie ?\nL'épilepsie peut-elle affecter la vie sociale ?\nY a-t-il un risque accru de dépression ?\nLes crises peuvent-elles entraîner des blessures graves ?\nComment les complications peuvent-elles être gérées ?", "url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=alpha-Linolenic+Acid&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Épilepsie partielle complexe", "description": "Quels sont les facteurs de risque de l'épilepsie partielle complexe ?\nL'âge influence-t-il le risque d'épilepsie ?\nLes maladies neurologiques augmentent-elles le risque ?\nLes facteurs environnementaux jouent-ils un rôle ?\nLe stress peut-il être un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=alpha-Linolenic+Acid&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on l'épilepsie partielle complexe ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique médical, l'EEG et l'imagerie cérébrale." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour confirmer le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'EEG et l'IRM sont essentiels pour visualiser l'activité cérébrale et les anomalies." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils varier d'un patient à l'autre ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent différer selon la localisation de l'activité épileptique." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à identifier les antécédents de crises et les facteurs déclenchants." } }, { "@type": "Question", "name": "Peut-on diagnostiquer l'épilepsie partielle complexe chez les enfants ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut se manifester chez les enfants, nécessitant une évaluation spécialisée." } }, { "@type": "Question", "name": "Quels sont les symptômes typiques des crises ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des mouvements involontaires, des hallucinations et des troubles de la conscience." } }, { "@type": "Question", "name": "Les crises peuvent-elles affecter la mémoire ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les crises peuvent entraîner des pertes de mémoire temporaires ou des confusions." } }, { "@type": "Question", "name": "Comment se manifestent les comportements automatisés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les comportements automatisés incluent des gestes répétitifs sans conscience de l'environnement." } }, { "@type": "Question", "name": "Les crises peuvent-elles être précédées d'aura ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes ressentent une aura, un signe avant-coureur de la crise." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils persister après la crise ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme la fatigue ou la confusion peuvent persister après la crise." } }, { "@type": "Question", "name": "Peut-on prévenir les crises d'épilepsie partielle complexe ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Bien qu'il soit difficile de prévenir, éviter les déclencheurs connus peut aider." } }, { "@type": "Question", "name": "Quels sont les déclencheurs courants des crises ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Le stress, le manque de sommeil et l'alcool sont des déclencheurs fréquents." } }, { "@type": "Question", "name": "L'éducation des proches est-elle importante ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, informer les proches sur les crises et les premiers secours est crucial." } }, { "@type": "Question", "name": "Les activités physiques sont-elles sûres ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Certaines activités peuvent être sûres, mais il est important de consulter un médecin." } }, { "@type": "Question", "name": "Comment gérer le stress pour prévenir les crises ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques de relaxation comme la méditation peuvent aider à gérer le stress." } }, { "@type": "Question", "name": "Quels médicaments sont couramment prescrits ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les anticonvulsivants comme la carbamazépine et la lamotrigine sont souvent utilisés." } }, { "@type": "Question", "name": "La chirurgie est-elle une option de traitement ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la chirurgie peut être envisagée si les médicaments ne contrôlent pas les crises." } }, { "@type": "Question", "name": "Quelles sont les alternatives aux médicaments ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les thérapies comportementales et la stimulation cérébrale peuvent être des options." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité du traitement ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité est évaluée par la fréquence des crises et les effets secondaires des médicaments." } }, { "@type": "Question", "name": "Les changements de mode de vie peuvent-ils aider ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sain, incluant sommeil et gestion du stress, peut aider." } }, { "@type": "Question", "name": "Quelles sont les complications possibles de l'épilepsie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent les blessures lors des crises et des problèmes psychologiques." } }, { "@type": "Question", "name": "L'épilepsie peut-elle affecter la vie sociale ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner des difficultés sociales et des stigmates associés." } }, { "@type": "Question", "name": "Y a-t-il un risque accru de dépression ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes épileptiques présentent un risque plus élevé de dépression et d'anxiété." } }, { "@type": "Question", "name": "Les crises peuvent-elles entraîner des blessures graves ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les chutes ou les accidents pendant une crise peuvent causer des blessures graves." } }, { "@type": "Question", "name": "Comment les complications peuvent-elles être gérées ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une prise en charge multidisciplinaire est essentielle pour gérer les complications." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de l'épilepsie partielle complexe ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux, les traumatismes crâniens et les infections cérébrales sont des facteurs de risque." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque d'épilepsie ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'épilepsie peut survenir à tout âge, mais elle est plus fréquente chez les jeunes enfants et les personnes âgées." } }, { "@type": "Question", "name": "Les maladies neurologiques augmentent-elles le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme la sclérose en plaques peuvent augmenter le risque d'épilepsie." } }, { "@type": "Question", "name": "Les facteurs environnementaux jouent-ils un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs comme l'exposition à des toxines peuvent contribuer au risque d'épilepsie." } }, { "@type": "Question", "name": "Le stress peut-il être un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut déclencher des crises chez certaines personnes épileptiques." } } ] } ] }

Sources (10000 au total)

Investigating the effects of co-supplementation with alpha-linolenic acid and L-carnitine on inflammatory status, oxidative stress, clinical symptoms, mental health and quality of life in women with migraine: a protocol for a randomized, triple-blind, placebo-controlled trial.

Migraine is a severe neurological disorder that is recognized as one of the most common debilitating diseases worldwide. Although the exact cause of migraine is not known, research suggests that infla... This is a parallel, randomized, triple-blind, placebo-controlled clinical trial, in which 80 women aged 20 to 50 years with migraine will be assigned to receive either intervention group (n = 40) rece... In this study, we aim to investigate the potential benefits of combining alpha-linolenic acid and L-carnitine as a treatment option for migraine sufferers. Migraine, characterized by recurrent severe ... Iranian Registry of Clinical Trials ( www.irct.ir ) (ID: IRCT20121216011763N57). Registration date: 29 March 2023.... The protocol is version 1.0 dated December 30, 2023. Recruitment began on July 10, 2023, and is expected to be completed by January 22, 2024....

Distinct effects of α-linolenic acid and docosahexaenoic acid on the expression of genes related to cholesterol metabolism and the response to infection in THP-1 monocytes and immune cells of obese humans.

Monocytes play a large role in chronic inflammatory conditions such as obesity, atherosclerosis and infection. Marine-derived omega-3 fatty acids such as docosahexaenoic acid (DHA) beneficially alter ... Transcriptome analysis was performed on THP-1 human monocytes treated with ALA, DHA or vehicle for 48 hr using fold change analysis, principal component analysis (PCA), partial least squares-discrimin... ALA and DHA-treated monocytes presented distinct transcriptomic profiles as per VIP and PLS-DA. Both fatty acids were predicted to reduce cellular cholesterol content, while ALA would uniquely increas... ALA and DHA differentially alter the transcription profiles and functions associated with the response to infection, chemotaxis, and cholesterol metabolism in mononuclear immune cells. Thus, they may ...

Identification of transcription factor BnHDG4-A08 as a novel candidate associated with the accumulation of oleic, linoleic, linolenic, and erucic acid in Brassica napus.

We screened 47 significantly associated haplotype blocks for oleic, linoleic, linolenic, and erucic acid, with 17 blocks influencing multiple traits. A novel candidate of transcription factor BnHDG4 A...

One-pot synthesis of α-Linolenic acid nanoemulsion-templated drug-loaded silica mesocomposites as efficient bactericide against drug-resistant Mycobacterium tuberculosis.

Nowadays, pathogenic infection has posed a severe threat to the public health and environmental sanitation, urging a continuous search of efficacious and safe bactericidal agents of various formulated...

Alpha-Linolenic Acid Ameliorates Cognitive Impairment and Liver Damage Caused by Obesity.

Obesity is a growing global problem that causes various complications such as diabetes, cognitive dysfunction, cardiovascular diseases, and hepatobiliary disease. Alpha-linolenic acid (ALA) has been r... Mice were fed with high-fat diet (HFD) and were treated with ALA (60 or 100 mg/kg). Body weight, adipose tissue, serum glucose and lipid levels, glucose resistance, and insulin resistance were measure... ALA treatment prevented HFD-induced adipose tissue accumulation, improved glucose and lipid homeostasis and metabolism. Administration of ALA repressed the HFD-induced increase in insulin levels and i... ALA treatment suppressed adipose accumulation in adipocytes, improved cognitive ability and colon integrity, and alleviated liver damage by modulating the 1-acylglycerol-3-phosphate O-acyltransferase ...

Natural remedies medicine derived from flaxseed (secoisolariciresinol diglucoside, lignans, and α-linolenic acid) improve network targeting efficiency of diabetic heart conditions based on computational chemistry techniques and pharmacophore modeling.

Cytokine storms lead to cardiovascular diseases (CVDs). Natural herbal compounds are considered the primary source of active agents with the potential to prevent or treat inflammatory-related patholog...